Patents by Inventor Debra L. Shade

Debra L. Shade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of AP-1 activators to treat glaucoma and ocular hypertension
    Patent number: 7005446
    Abstract: Compositions comprising AP-1 activators and methods of use for treating glaucoma and ocular hypertension are disclosed.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: February 28, 2006
    Assignee: Alcon Manufacturing, Ltd.
    Inventors: Debra L. Shade, Iok-Hou Pang, Abbot F. Clark
  • Use of ADNP for the treatment of glaucomatous optic neuropathy
    Publication number: 20030166544
    Abstract: Methods for preventing and treating glaucomatous optic neuropathy using peptides derived from or related to Activity Dependent Neuroprotective Factor (ADNP) are disclosed.
    Type: Application
    Filed: June 6, 2002
    Publication date: September 4, 2003
    Inventors: Abbot F. Clark, Debra L. Shade
  • Use of ADNF for the treatment of retinal or optic nerve head damage
    Publication number: 20020028763
    Abstract: Methods for treating retinal and/or optic nerve head damage using Activity Dependent Neurotrophic Factor are disclosed.
    Type: Application
    Filed: August 2, 2001
    Publication date: March 7, 2002
    Inventors: Debra L. Shade, Abbot F. Clark
  • Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
    Patent number: 5780450
    Abstract: Compositions and methods directed to the use of adenosine uptake inhibitors for the treatment of retinal and optic nerve head damage following acute or chronic glaucoma, edema, ischemia, hypoxia or trauma are disclosed.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: July 14, 1998
    Assignee: Alcon Laboratories, Inc.
    Inventor: Debra L. Shade